Document is current

200 Mio. Euro für Medikamente ohne Wirksamkeitsnachweis

Crossref DOI link: https://doi.org/10.1007/BF03367383

Published Online: 2016-06-11

Published Print: 2010-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy